2 terminated, 1 available. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow 3,5-diiodothyropropionic acid: new trials by email Literature Review of 3,5-diiodothyropropionic acid trials Research Report on 3,5-diiodothyropropionic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients 3,5-Diiodothyropropionic acid (DITPA) therapy - Hypercholesterolemia | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 60 | 2006-04-01 | 2013-04-02 |
| Study of DITPA in Patients With Congestive Heart Failure DITPA (3,5-diiodothyropropionic acid), Placebo - Heart Failure, Congestive | Phase 2 | Terminated | Titan Pharmaceuticals | 86 | 2004-12-01 | 2013-03-29 |
| Rescue of Infants With MCT8 Deficiency Diiodothyropropionic acid (DITPA) - Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency | Available | Roy E. Weiss, M.D. | 2025-12-11 |
Allan-Herndon-Dudley syndrome (1) · Heart Failure (1) · Hypercholesterolemia (1)
Johns Hopkins University (1) · Roy E. Weiss, M.D. (1) · Titan Pharmaceuticals (1)
United States (3)
Annabelle Rodriguez, MD (1) · Milton Packer, MD (1) · Roy E Weiss, M.D. (1)